THIS PAGE IS UNDER CONSTRUCTION Liraglutide (brand names Victoza® and Saxenda®) is an agonist at the glucagon−like peptide−1 receptor. Glucagon−like peptide−1 (GLP-1) is secreted from cells in the intestinal mucosa. It stimulates insulin secretion and inhibits glucagon secretion. The combined effect of these is to lower plasma glucose levels. What is the difference between Victoza®…